An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

We recently published a list of 12 Stocks That Could Split in the Near Future. In this article, we are going to take a look ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

In the latest trading session, Eli Lilly (LLY) closed at $773.29, marking a +1.07% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.11%. On the other hand, the Dow ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

Former New York Giants quarterback Eli Manning would consider becoming ... FanFest ambassador next month when the telecommunications company transforms stadiums across NFL markets into a one ...

PROVIDENCE, R.I. (AP) Kino Lilly Jr. had 16 points in Brown's 98-57 victory against Johnson & Wales on Sunday. Lilly also added eight assists for the Bears (8-5). N'famara Dabo scored 12 points ...

"After five years of working at Republic Garden and Lounge, Grace Lilly has exited the building," she shared in a confessional. "I've been doing some modeling and I just want to do like ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...